vimarsana.com

Page 2 - இந்தியன் மருந்து உற்பத்தியாளர்கள் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A tragedy of errors: 10 reasons behind India s catastrophic Covid crisis

ISSUE DATE: May 17, 2021 UPDATED: May 7, 2021 23:36 IST Staff at the Ghazipur crematorium in Delhi cart in fresh logs as funeral pyres burn all around them (Rajk Raj/ Getty Images) The second wave of Covid-19 is still cresting but by now we have all been touched by its terrors, and all too many of us by its sorrows and the dismal realisation that we are in the midst of a recurring nightmare, a tragedy foretold. Here, we expose the sorry tale of neglect, apathy and failure of our political leadership. The institutional collapse and bureaucratic cowardice that facilitated super-spreader religious festivals and the political carnival of an eight-phase election campaign even as the second wave of a pandemic was breaking. The narcissism that enabled our leadership to ignore the warnings of expert groups. Their inability to form bipartisan alliances between the Centre and the states in the middle of a national calamity. Now that some of the loudest voices in the land have gone quiet, t

Covid-19: Why is there a shortage of Remdesivir?- Business News

Inside Remdesivir puzzle: 6 producers, little supply! Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing PB Jayakumar | May 3, 2021 | Updated 19:22 IST Demand for Remdesivir fell to almost nil by January after the first wave of the pandemic in the country Reduction in production due to less demand after the first wave of coronavirus and lack of vigil on the part of the Government to ensure stockpiling led to current Remdesivir crisis, say sources. Gilead Life Sciences, the innovator of the re-purposed drug, had licensed six manufacturers in India to produce the drug. Most of them were dependent on contract manufacturers and their subsidiaries to make the product. Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing. Neith

Covid-19: Why is there a shortage of Remdesivir?

Covid-19: Why is there a shortage of Remdesivir? PB Jayakumar © India Today Group Covid-19: Why is there a shortage of Remdesivir? Reduction in production due to less demand after the first wave of coronavirus and lack of vigil on the part of the Government to ensure stockpiling led to current Remdesivir crisis, say sources. Gilead Life Sciences, the innovator of the re-purposed drug, had licensed six manufacturers in India to produce the drug.  Most of them were dependent on contract manufacturers and their subsidiaries to make the product. Demand fell to almost nil by January after the first wave of the pandemic in the country. Since  there was no demand, most manufacturers stopped giving fresh orders for manufacturing. Neither the manufacturers nor the policy makers anticipated a second wave and failed to stockpile the life saving drug, sources said.

Covid-19: Why is there a shortage of Remdesivir?- Business News

Covid-19: Why is there a shortage of Remdesivir?- Business News
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Container shortage, rising freight rates hit pharmaceutical exports

Container shortage, rising freight rates hit pharmaceutical exports April 08, 2021 × Shortage of empty containers, particularly reefer containers, and an almost 60 per cent surge in freight rates since October have hit export of pharmaceutical shipments from India. The Indian Drug Manufacturers Association said that ports in southern India have borne the brunt of box shortage prevailing over the last 7-8 months and have urged the Commerce Ministry to intervene and help tide over the crisis. The shortage of boxes, according to the association, has led to a rise in freight rates by almost 60 per cent. SV Veerramani, past national president of the Association, told

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.